Sorry, no content matched your criteria.
Featured Story
Why Gilead Stock Is a Good Buy for the Long Term
Gilead stock is still recovering from the decline of its once-booming hepatitis C business - that's what happens when you cure most of your customers.
But over the past year, with a new CEO, this biotech has taken steps that will return it to growth.
Wall Street doesn't realize it yet, but GILD is a stock to buy...
Gilead stock is still recovering from the decline of its once-booming hepatitis C business - that's what happens when you cure most of your customers.
But over the past year, with a new CEO, this biotech has taken steps that will return it to growth.
Wall Street doesn't realize it yet, but GILD is a stock to buy...